7-osteoarthritis and gout

Upload: michael-roland

Post on 05-Apr-2018

219 views

Category:

Documents


1 download

TRANSCRIPT

  • 7/31/2019 7-Osteoarthritis and Gout

    1/31

    DEGENERATIVE JOINTDISEASE:

    OSTEOARTHRIT

    IS (HYPERTROPHICARTHRITIS)

    Michael Roland E. Sumbe

  • 7/31/2019 7-Osteoarthritis and Gout

    2/31

    OSTEOARTHRITIS

    Aka degenerative jointdisease (althoughinflammation may be

    present) Chronic, nonsystemic

    disorder of jointscharacterized by

    DEGENERATION OFJOINT CARTILAGEand the formation ofreactive new bone at the

    margins of subchondral

  • 7/31/2019 7-Osteoarthritis and Gout

    3/31

    OSTEOARTHRITIS are affected,

    incidence increases with age. Also related toobesity and joint trauma

    Weigh bearing joints- spine, knees,hips and ends of fingers are most

    commonly affected.

  • 7/31/2019 7-Osteoarthritis and Gout

    4/31

    Causes:

    1.Primaryosteoarthritis

    ( a normal part of aging)

    Genetic factors (

    decreased collagensynthesis)

    Chemical factors(drugs such as steroids

    that stimulate thecollagen-digestingenzymes in synovialmembrane

    Mechanical factors(repeated stress on

  • 7/31/2019 7-Osteoarthritis and Gout

    5/31

    Genetic factors ( decreased collagen synthesis)

  • 7/31/2019 7-Osteoarthritis and Gout

    6/31

    Causes:

    2. Secondaryosteoarthritis(follows an

    identifiablepredisposing eventthat leads todegenerativechanges)

    Trauma (mostcommon cause)

    Congenitaldeformity

    Obesity

  • 7/31/2019 7-Osteoarthritis and Gout

    7/31

  • 7/31/2019 7-Osteoarthritis and Gout

    8/31

    Clinical manifestations:

    Pain aggravatedby use andrelieved by rest

    Stiffness of joints HEBERDENS

    NODES- bonyovergrowth at

    distalinterphalangealjoints : due torepeatedinflammation

  • 7/31/2019 7-Osteoarthritis and Gout

    9/31

    Clinicalmanifestations:

    BOUCHARDS

    NODES- bonyovergrowth at theproximal

    interphalangeal joints

    Decreased ROM :due to pain and

    stiffness

    crepitus: due tocartilage damage

    http://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis.avi
  • 7/31/2019 7-Osteoarthritis and Gout

    10/31

    Diagnosticfindings

    1. X-ray: narrowing ofjoint space andmargins

    2. Presence ofosteophytes andjoint spacenarrowing:

    sensitive andspecific findings

    3. Radionuclide bonescan: rule out

    inflammatory

  • 7/31/2019 7-Osteoarthritis and Gout

    11/31

    Diagnostic findings

    4. MRI: shows affectedjoint, adjacent bonesand disease progression

    5. Arthroscopy: showsinternal joint structures

    and identifies soft-tissueswelling

  • 7/31/2019 7-Osteoarthritis and Gout

    12/31

    Collaborative management:

    Weight loss to reduce extra stress on weight-bearing joints

    Exercise to keep joints flexible and improve

    muscle strength Heat and cold therapy for temporary pain relief.

  • 7/31/2019 7-Osteoarthritis and Gout

    13/31

    Collaborative management:

    Relieve strain and prevent further trauma tojoints: Use cane or walker when indicated

    Maintain good posture and body mechanics,avoid excessive weight-bearing andcontinuous standing

    Physical therapy to maintain joint mobilityand muscle strength

    Promote comfort relief of pain ( analgesicsand NSAIDS)

    Joint replacement as needed

  • 7/31/2019 7-Osteoarthritis and Gout

    14/31

    Viscosupplementation theintra-articular injection of hyaluronic

    acid. Thought to improve cartilage

    function and retard degradation and

    have anti-inflammatory effects.

    Hyaluronic acid aglycosaminoglycan that acts as alubricant and shock-absorbing fluidin the joint. It stimulates theproduction of synoviocytes,

    possibly providing better and moreprolonged pain control

    videos\Osteoarthritis and Rheumatoid

    Arthritis.avi

    http://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis%20and%20Rheumatoid%20Arthritis.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis%20and%20Rheumatoid%20Arthritis.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis%20and%20Rheumatoid%20Arthritis.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis%20and%20Rheumatoid%20Arthritis.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis%20and%20Rheumatoid%20Arthritis.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Osteoarthritis%20and%20Rheumatoid%20Arthritis.avi
  • 7/31/2019 7-Osteoarthritis and Gout

    15/31

    ASSOCIATED WITH RHEUMATIC

    DISORDERS:

    GOUT

    ARTHRITIS

    Michael Roland E. Sumbe

  • 7/31/2019 7-Osteoarthritis and Gout

    16/31

    GOUT ARTHRITIS

    Heterogenous group of conditions related to geneticdefect of purine metabolism resulting in

    hyperuricemia ( serum concentration greaterthan 7 mg/dL)

    Oversecretion of uric acid or renal defect resultingin decreased excretion of uric acid or a combinationof both occurs

    Characterized by high levels of uric acid in the bloodand in the urine

    There is precipitation of urate crystals ( tophi) inthe joints. This causes inflammation and pain

    Occurs most often in males; and it is familial

  • 7/31/2019 7-Osteoarthritis and Gout

    17/31

    Causes:

    Genetic defect in purinemetabolism causinghyperuricemia

    Retention of uric

    acid Combination of the above

  • 7/31/2019 7-Osteoarthritis and Gout

    18/31

    Risk factors: Severe dieting or starvation

    Excessive intake of foods highin purines ( shellfish, organmeats)

    Hereditary : commonly in

    males Medications such as diuretics

    and salicylates

    Increasing age

    Hypertension

  • 7/31/2019 7-Osteoarthritis and Gout

    19/31

    Pathophysiology:

    Attacks of gout appear to be related to

    sudden decrease or increase of serum

    uric acid level

    Uric acid becomes supersaturated in theblood and body fluids

    Uric acid then crystallizes and forms a

    precipitate of urate salts thataccumulates in connective tissuethroughout the body

  • 7/31/2019 7-Osteoarthritis and Gout

    20/31

    Pathophysiology: With repeated attacks,

    accumulations of sodium uratecrystal called TOPHI are depositedin the peripheral areas of the bodysuch as great toe, hands and

    the ear.

    Crystal deposits triggerinflammatory response whenneutrophils begin to ingest them

    Neutrophils release lysosomesthatdamage tissues and perpetuatethe inflammation

    http://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Body%20Invaders%20%20Gout.flv.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Body%20Invaders%20%20Gout.flv.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Body%20Invaders%20%20Gout.flv.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Body%20Invaders%20%20Gout.flv.avi
  • 7/31/2019 7-Osteoarthritis and Gout

    21/31

  • 7/31/2019 7-Osteoarthritis and Gout

    22/31

    Clinical manifestations:

    elevated skin

    temperature: due to

    inflammation

    Renal urate lithiasis(kidney stones) with

    chronic renal disease

    secondary to urate

    deposition may

    develop

  • 7/31/2019 7-Osteoarthritis and Gout

    23/31

    FOUR clinicaL phases:

    1. Asymptomatic hyperurecemia

    Serum urate level is elevated even though there

    are no symptoms.

    2. Acute Gouty Arthritis There is a sudden onset of severe pain in the

    great toe or occasionally the heel, ankle, wrist,

    fingers and elbows.

    When the urate crystals are deposited in the

    synovial fluids they can rapidly lyse neutrophils

    which release lysosomal enzymes ---

    INFLAMMATION

  • 7/31/2019 7-Osteoarthritis and Gout

    24/31

    THE joints become red, hot and tender. The pain

    become intense! Fever and elevated WBC.

    If untreated, lasts for 3-14 days.

    3. Intercritical Gout The intervals between attacks

    4. Chronic tophaceous gout Tophi occur in many locations

  • 7/31/2019 7-Osteoarthritis and Gout

    25/31

    MANAGEMENT:

    ACUTE ATTACK:COLCHICINE [oral or IV]every 8 hours ( discontinueif diarrhea or nausea andvomiting occur ,or NSAIDs (

    Indocin, Butazolidin)Inhibits Phagocytosis of

    uric acid crystals byneutrophils

    Given until the painsubsides ornauseaand vomiting,cramping or diarrheadevelops

  • 7/31/2019 7-Osteoarthritis and Gout

    26/31

    Immobilization and protection of the

    inflamed , painful joints

    Local application of heat to stimulate

    circulation in the area and clear cellular

    debris from the inflammation Local application of cold to decrease pain

    Increase fluid intake ( 3L/day) if not

    contraindicated to prevent renal calculi NSAIDS to reduce pain and inflammation

  • 7/31/2019 7-Osteoarthritis and Gout

    27/31

    b. CHRONIC

    GOUT

    Maintenance dosages of

    ALLOPURINOL to suppressuric acid formation or control of

    uric acid levels, preventingfurther attacks ( used

    cautiously with renal failure)

    Cholchicine to prevent

    recurrent acute attack

  • 7/31/2019 7-Osteoarthritis and Gout

    28/31

    b. CHRONIC GOUT Uricosuric Agents- these are

    agents that increases excretion ofuric acid in the urine

    Benemid ( Probenecid),Anturane ( sulfinpyrazone)

    Zyloprim ( allopurinol)- inhibitsuric acid formation Avoid purine-rich foods ( Organ

    meats, shellfish, legumes, sardines,salted anchovies, mushrooms,herring, sweetbreads, beer andwine )

  • 7/31/2019 7-Osteoarthritis and Gout

    29/31

    Nursing interventions in antigout

    medications:

    Should be used cautiously in clients with GI,

    renal, cardiac and hepatic diseases

    Maintain a fluid intake of at least 2-3L a day to

    avoid kidney stones Instruct client to avoid alcohol and caffeine.

    These products can increase uric acid level

    Avoid purine-rich foods ( caffeine, alcohol,organ meats, sardines, salmon, scallops and

    gravy)

  • 7/31/2019 7-Osteoarthritis and Gout

    30/31

    Nursing interventions in antigout

    medications:

    Instruct client to take medications with food. To

    prevent GI irritation

    Instruct client to avoid large doses of vitamin C

    while taking allopurinol to prevent kidneystones

    Advise client to have yearly eye examination.

    Visual changes can occur from prolongedused of allopurinol

    Do not take ASA with antigout medications. To

    prevent gout hypoglycaemic agents.

  • 7/31/2019 7-Osteoarthritis and Gout

    31/31

    Nursing interventions in antigout

    medications:

    Observe for the ff. side-effects of antigoutmedications;

    Headache

    Nausea and vomiting, diarrhea

    Bone marrow depression

    Flushed skin and skin rash

    Uric acid kidney stone

    Sore gumsMetallic taste

    videos\Arthritis Gout.avi

    http://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Arthritis%20%20Gout.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Arthritis%20%20Gout.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Arthritis%20%20Gout.avihttp://localhost/var/www/apps/conversion/current/tmp/scratch14171/videos/Arthritis%20%20Gout.avi